What AML Mutations Are Associated With Adverse Outcomes?

https://vimeo.com/794307363 Which acute myeloid leukemia (AML) mutations are linked to adverse outcomes? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center shares insight..Learn about different mutations, treatment…

What Does Triplet Therapy in AML Mean for the Future?

https://vimeo.com/794307058 What do acute myeloid leukemia (AML) patients need to know about triplet therapy? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center shares his perspective. Learn…

A Look at Lower Intensity Chemotherapy in Untreated AML

https://vimeo.com/794306977 Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses whether untreated acute myeloid leukemia (AML) can be treated with lower intensity chemotherapy. [ACT]IVATION TIP “Ask your…

A Look at Treatment Strategies for High-Risk AML Patients

https://vimeo.com/794306813 What acute myeloid leukemia (AML) treatments are available for high-risk patients? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses various mutations, potential for cure,…

Why Is the Menin Pathway Important in AML?

https://vimeo.com/794306732 What should acute myeloid leukemia (AML) patients know about the menin pathway? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center shares information from ASH 2022….

The Importance of the FLT3 Mutation in AML

https://vimeo.com/794306585 What do acute myeloid leukemia (AML) patients need to  know about FLT3 mutation? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses considerations about the…

Share On:

Facebook
Twitter
LinkedIn